<DOC>
	<DOCNO>NCT00351325</DOCNO>
	<brief_summary>The purpose study assess safety tolerability multiple escalate dos BMS-663513 give combination paclitaxel carboplatin .</brief_summary>
	<brief_title>A Study BMS-663513 Administered Combination With Chemotherapy Subjects With Advanced Solid Malignancies</brief_title>
	<detailed_description />
	<mesh_term>Neoplasms</mesh_term>
	<criteria>Good activity level Life expectancy â‰¥ 6 month Solid tumor malignancy paclitaxel carboplatin appropriate Major surgery within 4 week Any concurrent cancer History autoimmune diseases Symptomatic bowel obstruction Continued use steroid Symptomatic brain metastasis Current nerve damage fingers/toes Positive HIV , hepatitis B/C White blood cell &lt; 3,000 Hemoglobin &lt; 9 Platelets &lt; 100,000 ALT/AST and/or alkaline phosphatase &gt; = 2.5 x ULN Creatine &gt; 1.5 Prior BMS663513</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2009</verification_date>
</DOC>